AstraZeneca | 6-K: AstraZeneca to Deliver $80bn Revenue by 2030
6-K: Q1 2024 Results
ASTRAZENECA | 6-K: Report of foreign private issuer (related to financial reporting)
ASTRAZENECA | 20-F: Registration statement / Annual report / Transition report
ASTRAZENECA | 6-K: Report of foreign private issuer (related to financial reporting)
ASTRAZENECA | 6-K: Report of foreign private issuer (related to financial reporting)
ASTRAZENECA | 6-K: Report of foreign private issuer (related to financial reporting)
ASTRAZENECA | 6-K: Report of foreign private issuer (related to financial reporting)
ASTRAZENECA | 6-K: Report of foreign private issuer (related to financial reporting)
ASTRAZENECA | 6-K: Report of foreign private issuer (related to financial reporting)
ASTRAZENECA: FY2022 Annual Report
20-F | ASTRAZENECA PLC (0000901832) (Filer)
ASTRAZENECA | 6-K: Report of foreign private issuer (related to financial reporting)
ASTRAZENECA | 6-K: Report of foreign private issuer (related to financial reporting)
ASTRAZENECA | 6-K: Report of foreign private issuer (related to financial reporting)
ASTRAZENECA | 6-K: Report of foreign private issuer (related to financial reporting)
ASTRAZENECA | 6-K: Report of foreign private issuer (related to financial reporting)
ASTRAZENECA | 20-F: FY2021 Annual Report
ASTRAZENECA | 6-K: Report of foreign private issuer (related to financial reporting)
ASTRAZENECA | 6-K: Report of foreign private issuer (related to financial reporting)
ASTRAZENECA | 20-F: FY2020 Annual Report
No Data